This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

Melanie Senior
Senior Writer & Analyst at Nature Portfolio; Evaluate Pharma


Melanie writes about science, strategy, investment and market access for Evaluate Pharma, Nature Biotechnology, IN VIVO and other publications. She also supports international biopharmaceutical companies and associations in clearly communicating their mission and market positioning.

After beginning her career at the London Financial Times, Melanie became Bureau Chief, Europe, for Elsevier Business Intelligence. She worked as a reimbursement and pricing analyst for Real Endpoints in the US and was part of EY Life Sciences’ thought leadership team between 2014-2017.

Melanie holds a First class degree in Natural Sciences (biochemistry) from Cambridge University and has post-graduate qualifications in Sports Physiology & Nutrition (St Mary’s University) and in International Health Technology Assessment (University of Sheffield). She is based in London, UK.

Agenda Sessions

  • The revolution in obesity treatment: in conversation with Axel Haupt